| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.40e-05 | 127 | 134 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 BRIP1 ZCWPW2 ATAD5 ZGRF1 LARS1 ZNFX1 MSH5 RFC1 DDX10 ERVK-8 ERCC6L2 HFM1 PARN TRMT1L | 2.90e-05 | 645 | 134 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | DNA clamp unloader activity | 4.47e-05 | 2 | 134 | 2 | GO:0061860 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 7.04e-05 | 262 | 134 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | helicase activity | 9.63e-05 | 158 | 134 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNA ANK3 CAPG POSTN NEO1 FBN1 CDH20 NRXN1 TENM3 DMD PALLD CDH8 PHLDB2 | 2.00e-04 | 599 | 134 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | ATP-dependent activity | BRIP1 ZCWPW2 ATAD5 ZGRF1 ZNFX1 MSH5 RFC1 ABCB1 DDX10 ERCC6L2 HFM1 ATP2B3 SLC27A4 | 2.55e-04 | 614 | 134 | 13 | GO:0140657 |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-6 SHLD2 TICRR BRIP1 MAPT ATAD5 ZGRF1 MSH5 RFC1 NDUFS6 TAF9B ERVK-8 ERCC6L2 SMARCB1 BOD1L1 ATM SPRTN FH NEK11 | 1.02e-05 | 959 | 131 | 19 | GO:0006974 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.48e-05 | 83 | 131 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | chromosome organization | SHLD2 FLNA BRIP1 CENPC MAPT ZGRF1 MSH5 RFC1 AKAP8L RESF1 SMARCB1 PINX1 HFM1 PARN ATM | 3.10e-05 | 686 | 131 | 15 | GO:0051276 |
| GeneOntologyBiologicalProcess | DNA clamp unloading | 4.00e-05 | 2 | 131 | 2 | GO:0090618 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 SHLD2 TICRR BRIP1 ZGRF1 MSH5 RFC1 ERVK-8 ERCC6L2 SMARCB1 BOD1L1 ATM SPRTN FH | 6.59e-05 | 648 | 131 | 14 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA integration | 6.84e-05 | 13 | 131 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 1.20e-04 | 3 | 131 | 2 | GO:0071691 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.04e-05 | 45 | 135 | 5 | GO:0044295 | |
| GeneOntologyCellularComponent | Z disc | 5.71e-05 | 151 | 135 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 1.04e-04 | 166 | 135 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | Elg1 RFC-like complex | 1.24e-04 | 3 | 135 | 2 | GO:0031391 | |
| GeneOntologyCellularComponent | myofibril | 4.05e-04 | 273 | 135 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | anchoring junction | FLNA NRAP ANK3 ASH1L ABCB1 NEDD9 DOCK5 FAT2 CDH20 NRXN1 XIRP2 ANO7 DMD PALLD CDH8 PHLDB2 | 5.68e-04 | 976 | 135 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.03e-04 | 290 | 135 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 6.11e-04 | 6 | 135 | 2 | GO:0098591 | |
| GeneOntologyCellularComponent | neuromuscular junction | 8.05e-04 | 112 | 135 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | sarcomere | 1.19e-03 | 249 | 135 | 7 | GO:0030017 | |
| MousePheno | increased Harderian gland tumor incidence | 8.34e-06 | 6 | 106 | 3 | MP:0012437 | |
| Pubmed | NEPRO NRAS ATAD5 ACAD9 MKRN1 ZMYM2 GON4L SRP72 SRBD1 SPECC1 AKAP8L MYEF2 DDX10 TOMM70 PIGT PTPN13 UBP1 CTR9 GNL2 ANKRD11 PARN TRMT1L FHIP1A EDRF1 | 3.95e-09 | 1497 | 136 | 24 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA BRIP1 CENPC ATAD5 ZMYM2 SRP72 ZDBF2 RFC1 NDUFS6 DDX10 EFTUD2 TAF3 TAF9B GNL2 ANKRD11 PINX1 PARN BOD1L1 PLRG1 | 6.57e-09 | 954 | 136 | 19 | 36373674 |
| Pubmed | FLG FLNA CENPC ZNF658 PCLO BIVM ASH1L SRP72 SRBD1 NEB AKAP8L ABCB1 ZBED4 NRXN1 CTR9 BOD1L1 ATM DMD ATP2B3 SLC27A4 ZNF292 VAT1 | 4.59e-08 | 1442 | 136 | 22 | 35575683 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ANK3 ACAD9 NEB AKAP8L XIRP2 ERCC6L2 GNL2 ANKRD11 SMARCB1 ATM PLRG1 HYDIN ZNF292 | 8.69e-08 | 497 | 136 | 13 | 36774506 |
| Pubmed | ATAD5 ZMYM2 ZNFX1 ZDBF2 RFC1 NEB MYEF2 SLC38A1 PIGT UBP1 SMARCB1 HFM1 WDFY3 ATP2B3 | 2.31e-07 | 638 | 136 | 14 | 31182584 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNA NEPRO NRAS CENPC ZMYM2 RFC1 SRBD1 AKAP8L DDX10 EFTUD2 CTR9 GNL2 PINX1 PARN BOD1L1 PLRG1 SLC27A4 | 3.52e-07 | 989 | 136 | 17 | 36424410 |
| Pubmed | 3.86e-07 | 234 | 136 | 9 | 36243803 | ||
| Pubmed | FLNA ANK3 VPS8 ASH1L ZMYM2 SRP72 ZZEF1 NEDD9 MAST4 TENM3 CTR9 PLCL2 SPRTN | 6.21e-07 | 591 | 136 | 13 | 15231748 | |
| Pubmed | DOCK3 ANK3 CEP290 ASH1L HECTD4 LARS1 ZMYM2 ZNFX1 BTBD1 SPECC1 AKAP8L PTPN13 FBN1 CTR9 LRP4 ATM WDFY3 TBC1D23 ZNF292 | 6.70e-07 | 1285 | 136 | 19 | 35914814 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNA NRAS ANK3 PCLO ASH1L LARS1 SAXO1 ZZEF1 MYEF2 EFTUD2 TOMM70 ZNF561 FH HYDIN VAT1 | 6.86e-07 | 807 | 136 | 15 | 30575818 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA TRAF1 ACAD9 PCLO LARS1 SRP72 RFC1 DDX10 EFTUD2 SLC38A1 TOMM70 CTR9 GNL2 BOD1L1 ATM FH ATP2B3 PLRG1 SLC27A4 VAT1 | 7.45e-07 | 1425 | 136 | 20 | 30948266 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | BRIP1 CENPC ATAD5 ZMYM2 RFC1 SRBD1 DDX10 TAF3 GNL2 SMARCB1 PINX1 BOD1L1 ZNF292 | 8.53e-07 | 608 | 136 | 13 | 36089195 |
| Pubmed | SHLD2 FLNA TICRR ANK3 ACAD9 CAPG ASH1L ZNF429 MSH5 PTPN13 RESF1 PTPRR UBP1 CTR9 PLCL2 BOD1L1 ZMAT1 | 1.24e-06 | 1084 | 136 | 17 | 11544199 | |
| Pubmed | C12orf56 GON4L SRP72 ZNFX1 ZZEF1 AKAP8L DOCK5 TOMM70 CTR9 PARN PLRG1 PALLD SLC27A4 | 1.78e-06 | 650 | 136 | 13 | 38777146 | |
| Pubmed | 2.52e-06 | 153 | 136 | 7 | 10718198 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CASP8AP2 TICRR ATAD5 CEP290 ZMYM2 RFC1 SRBD1 NDUFS6 EFTUD2 DOCK5 TAF9B ZBED4 UBP1 CTR9 ANKRD11 SMARCB1 PLRG1 SLC27A4 | 3.19e-06 | 1294 | 136 | 18 | 30804502 |
| Pubmed | ANK3 CENPC ATAD5 CEP290 AKAP8L SLC38A1 POSTN TOMM70 PTPN13 PTPRR CTR9 PLCL2 GNL2 PINX1 DMD VAT1 | 3.71e-06 | 1049 | 136 | 16 | 27880917 | |
| Pubmed | NRAP MKRN1 GON4L SRP72 BTBD1 NEB NEDD9 TOMM70 NEO1 XIRP2 PALLD | 4.45e-06 | 497 | 136 | 11 | 23414517 | |
| Pubmed | 4.54e-06 | 403 | 136 | 10 | 35253629 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG HECTD4 ZMYM2 SRP72 AKAP8L MYEF2 EFTUD2 TAF3 PTPN13 ZBED4 NRXN1 GNL2 SMARCB1 ATM PLRG1 ZNF292 | 5.48e-06 | 1082 | 136 | 16 | 38697112 |
| Pubmed | FLNA NEPRO LARS1 SRP72 RFC1 SRBD1 EFTUD2 GNL2 SMARCB1 TRMT1L PLRG1 PALLD | 5.82e-06 | 615 | 136 | 12 | 31048545 | |
| Pubmed | ANK3 RASA3 SPECC1 AKAP8L SLC38A1 PTPN13 TENM3 DMD PHLDB2 VAT1 | 6.66e-06 | 421 | 136 | 10 | 36976175 | |
| Pubmed | 7.39e-06 | 32 | 136 | 4 | 12493773 | ||
| Pubmed | 8.99e-06 | 71 | 136 | 5 | 33541421 | ||
| Pubmed | 9.43e-06 | 11 | 136 | 3 | 22065784 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | TICRR NEPRO ATAD5 LARS1 SRP72 RFC1 SRBD1 AKAP8L DDX10 GNL2 PINX1 TRMT1L PLRG1 | 9.50e-06 | 759 | 136 | 13 | 35915203 |
| Pubmed | 1.28e-05 | 130 | 136 | 6 | 12421765 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34294193 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 20668298 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28644349 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 29912990 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17237794 | ||
| Pubmed | DOCK3 regulates normal skeletal muscle regeneration and glucose metabolism. | 1.52e-05 | 2 | 136 | 2 | 37742307 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 33955002 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32766788 | ||
| Pubmed | Duchenne-like myopathy in double-mutant mdx mice expressing exaggerated mast cell activity. | 1.52e-05 | 2 | 136 | 2 | 7561939 | |
| Pubmed | Histone methyltransferase Ash1L mediates activity-dependent repression of neurexin-1α. | 1.52e-05 | 2 | 136 | 2 | 27229316 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 26055704 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 30281092 | ||
| Pubmed | Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy. | 1.52e-05 | 2 | 136 | 2 | 33987657 | |
| Pubmed | Direct and Indirect Effects of Filamin A on Tau Pathology in Neuronal Cells. | 1.52e-05 | 2 | 136 | 2 | 36399251 | |
| Pubmed | Mutational analysis of FLASH and PTPN13 genes in colorectal carcinomas. | 1.52e-05 | 2 | 136 | 2 | 18038312 | |
| Pubmed | Periostin Is Required for the Maintenance of Muscle Fibers during Muscle Regeneration. | 1.52e-05 | 2 | 136 | 2 | 33807264 | |
| Pubmed | 2.17e-05 | 483 | 136 | 10 | 36912080 | ||
| Pubmed | 2.43e-05 | 87 | 136 | 5 | 12465718 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.65e-05 | 394 | 136 | 9 | 27248496 | |
| Pubmed | MAPT ATAD5 ASH1L ZZEF1 AKAP8L MYEF2 TAF3 RESF1 TAF9B GNL2 SMARCB1 LRP4 WDFY3 PHLDB2 ARAP2 | 3.32e-05 | 1116 | 136 | 15 | 31753913 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | GALNTL6 CFAP47 TICRR PCLO CEP290 ZZEF1 DOCK5 CDH20 ZBED4 FBXO43 BOD1L1 ATM | 3.43e-05 | 736 | 136 | 12 | 29676528 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAPT RASSF2 SPECC1 PTPN13 RESF1 MAST4 ANKRD11 BOD1L1 PALLD EDRF1 CFAP97 PHLDB2 ARAP2 | 3.53e-05 | 861 | 136 | 13 | 36931259 |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 3.66e-05 | 316 | 136 | 8 | 31665637 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ACAD9 CEP290 SRP72 AKAP8L DDX10 TOMM70 PIGT PTPN13 FBN1 GNL2 PHLDB2 SLC27A4 | 4.33e-05 | 754 | 136 | 12 | 33060197 |
| Pubmed | FLG NEPRO ATAD5 LARS1 ZMYM2 GON4L SRP72 RFC1 AKAP8L DDX10 TAF3 FBN1 RESF1 TAF9B GNL2 SMARCB1 TRMT1L | 4.49e-05 | 1429 | 136 | 17 | 35140242 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 31754018 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 21924255 | ||
| Pubmed | Rac activation and inactivation control plasticity of tumor cell movement. | 4.54e-05 | 3 | 136 | 2 | 18984162 | |
| Pubmed | A conserved interaction that is essential for the biogenesis of histone locus bodies. | 4.54e-05 | 3 | 136 | 2 | 25339177 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 27356871 | ||
| Pubmed | The FANCJ helicase unfolds DNA-protein crosslinks to promote their repair. | 4.54e-05 | 3 | 136 | 2 | 36608669 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 32240725 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 27503929 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 20236936 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 32722282 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 22190510 | ||
| Pubmed | CASP8AP2 CENPC ATAD5 CAPG RFC1 TAF3 PHPT1 CTR9 SMARCB1 PARN BOD1L1 ATM TRMT1L PLRG1 | 4.62e-05 | 1014 | 136 | 14 | 32416067 | |
| Pubmed | FLNA ACAD9 VPS8 LARS1 SRP72 RFC1 SPECC1 AKAP8L EFTUD2 TOMM70 PIGT GNL2 LRP4 ATM TRMT1L SLC27A4 ALPP | 4.94e-05 | 1440 | 136 | 17 | 30833792 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 5.17e-05 | 332 | 136 | 8 | 32786267 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | FLG ANK3 ACAD9 CEP290 LARS1 EFTUD2 DOCK5 POSTN PIGT PTPN13 NRXN1 CTR9 PLCL2 EDRF1 FYB2 PHLDB2 | 6.19e-05 | 1321 | 136 | 16 | 27173435 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.24e-05 | 341 | 136 | 8 | 32971831 | |
| Pubmed | 7.26e-05 | 177 | 136 | 6 | 26206133 | ||
| Pubmed | Discovery and characterization of spontaneous mouse models of craniofacial dysmorphology. | 7.39e-05 | 21 | 136 | 3 | 26234751 | |
| Pubmed | 7.76e-05 | 453 | 136 | 9 | 29656893 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA CENPC RASA3 LARS1 RFC1 SRBD1 AKAP8L MYEF2 DDX10 EFTUD2 CTR9 WDFY3 PLRG1 PALLD PHLDB2 SLC27A4 | 8.19e-05 | 1353 | 136 | 16 | 29467282 |
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 16055729 | ||
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 10655059 | ||
| Pubmed | ATAD5 regulates the lifespan of DNA replication factories by modulating PCNA level on the chromatin. | 9.06e-05 | 4 | 136 | 2 | 23277426 | |
| Pubmed | Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation. | 9.06e-05 | 4 | 136 | 2 | 16355270 | |
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 23985323 | ||
| Pubmed | 9.06e-05 | 4 | 136 | 2 | 18557994 | ||
| Pubmed | Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo. | 9.06e-05 | 4 | 136 | 2 | 16902413 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.00e-04 | 271 | 136 | 7 | 32433965 | |
| Pubmed | 1.01e-04 | 469 | 136 | 9 | 27634302 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.10e-04 | 370 | 136 | 8 | 22922362 | |
| Pubmed | 1.28e-04 | 282 | 136 | 7 | 23667531 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.41e-04 | 605 | 136 | 10 | 28977666 | |
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 24789910 | ||
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 28191889 | ||
| Pubmed | An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. | 1.51e-04 | 5 | 136 | 2 | 19109891 | |
| Pubmed | An anthropoid-specific segmental duplication on human chromosome 1q22. | 1.51e-04 | 5 | 136 | 2 | 16545939 | |
| Pubmed | 1.51e-04 | 5 | 136 | 2 | 15640358 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FLNA LARS1 SRP72 RFC1 AKAP8L DDX10 EFTUD2 TAF3 TAF9B CTR9 GNL2 SMARCB1 TRMT1L FH PLRG1 | 2.09e-04 | 1318 | 136 | 15 | 30463901 |
| Pubmed | 2.10e-04 | 407 | 136 | 8 | 12693553 | ||
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 30295604 | ||
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 19805520 | ||
| Pubmed | 2.25e-04 | 6 | 136 | 2 | 11468690 | ||
| Pubmed | Dysregulation of NRAP degradation by KLHL41 contributes to pathophysiology in nemaline myopathy. | 2.25e-04 | 6 | 136 | 2 | 30986853 | |
| Pubmed | CASP8AP2 ANK3 CENPC ATAD5 ACAD9 NDUFS6 DDX10 EFTUD2 NEO1 PTPN13 CTR9 GNL2 ANKRD11 ATM PLRG1 EDRF1 | 2.40e-04 | 1487 | 136 | 16 | 33957083 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA BRIP1 MAPT ZMYM2 RFC1 AKAP8L EFTUD2 TAF3 CTR9 ATM PHLDB2 | 2.43e-04 | 774 | 136 | 11 | 15302935 |
| Pubmed | 2.51e-04 | 418 | 136 | 8 | 34709266 | ||
| Pubmed | 2.55e-04 | 419 | 136 | 8 | 15635413 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.61e-04 | 533 | 136 | 9 | 30554943 | |
| Interaction | H3C1 interactions | BRIP1 ANK3 CENPC MAPT ATAD5 CEP290 ASH1L ZMYM2 SRP72 RFC1 SRBD1 NEB ZZEF1 DDX10 EFTUD2 TAF3 XIRP2 CTR9 GNL2 PINX1 PARN ATM PALLD ZNF292 | 4.11e-09 | 901 | 132 | 24 | int:H3C1 |
| Interaction | NUP43 interactions | CASP8AP2 FLNA NEPRO BRIP1 CENPC ASH1L ZMYM2 GON4L ZDBF2 RFC1 TAF3 FBN1 RESF1 TAF9B GNL2 ANKRD11 PARN BOD1L1 TRMT1L ZNF292 | 4.55e-09 | 625 | 132 | 20 | int:NUP43 |
| Interaction | FLNC interactions | 3.33e-06 | 234 | 132 | 10 | int:FLNC | |
| Interaction | POLR1G interactions | NEPRO CENPC ATAD5 RFC1 DDX10 TAF3 TAF9B CTR9 GNL2 ANKRD11 PINX1 PARN TRMT1L ZNF292 | 4.08e-06 | 489 | 132 | 14 | int:POLR1G |
| Interaction | SNRNP40 interactions | CASP8AP2 FLNA NEPRO BRIP1 CENPC ATAD5 GON4L ZDBF2 RFC1 SRBD1 EFTUD2 TAF9B GNL2 PINX1 TRMT1L PLRG1 | 4.33e-06 | 637 | 132 | 16 | int:SNRNP40 |
| Interaction | NIFK interactions | NEPRO CENPC ATAD5 SRP72 RFC1 DDX10 EFTUD2 TAF3 GNL2 ANKRD11 PINX1 PARN TRMT1L | 5.25e-06 | 431 | 132 | 13 | int:NIFK |
| Interaction | ZNF330 interactions | NEPRO CENPC ATAD5 RFC1 SRBD1 DDX10 TAF3 CTR9 GNL2 ANKRD11 PINX1 PARN ZNF292 | 7.59e-06 | 446 | 132 | 13 | int:ZNF330 |
| Interaction | FBXO22 interactions | ANK3 ACAD9 NEB AKAP8L EFTUD2 XIRP2 ERCC6L2 GNL2 ANKRD11 SMARCB1 ATM PLRG1 HYDIN ZNF292 | 1.26e-05 | 540 | 132 | 14 | int:FBXO22 |
| Interaction | SMC5 interactions | FLNA BRIP1 CENPC ATAD5 ZMYM2 SRP72 ZDBF2 RFC1 NDUFS6 DDX10 EFTUD2 TAF3 TAF9B GNL2 ANKRD11 PINX1 PARN BOD1L1 PLRG1 | 2.81e-05 | 1000 | 132 | 19 | int:SMC5 |
| Interaction | H3-3A interactions | BRIP1 CENPC MAPT ATAD5 ASH1L ZMYM2 RFC1 SRBD1 DDX10 TAF3 GNL2 SMARCB1 PINX1 BOD1L1 FH ZNF292 | 3.21e-05 | 749 | 132 | 16 | int:H3-3A |
| Interaction | H2BC9 interactions | CASP8AP2 PCLO CEP290 ASH1L NEB TOMM70 XIRP2 UBP1 WDFY3 SPRTN ATP2B3 PALLD | 3.78e-05 | 446 | 132 | 12 | int:H2BC9 |
| Interaction | RPL31 interactions | NEPRO CENPC MAPT ATAD5 MKRN1 SRP72 RFC1 DDX10 EFTUD2 TAF3 GNL2 ANKRD11 PINX1 PARN TRMT1L | 4.00e-05 | 680 | 132 | 15 | int:RPL31 |
| Interaction | RPS6 interactions | NEPRO CENPC MAPT PCLO LARS1 SRP72 RFC1 AKAP8L MYEF2 DDX10 EFTUD2 GVINP1 GNL2 PINX1 PARN TRMT1L SPRTN | 5.78e-05 | 874 | 132 | 17 | int:RPS6 |
| Interaction | MAGEA9 interactions | 6.94e-05 | 208 | 132 | 8 | int:MAGEA9 | |
| Interaction | TERF2IP interactions | BRIP1 CENPC ATAD5 ZMYM2 RFC1 DDX10 TAF9B ANKRD11 PINX1 PARN BOD1L1 WDFY3 ZNF292 | 6.98e-05 | 552 | 132 | 13 | int:TERF2IP |
| Interaction | MAGEB2 interactions | 1.03e-04 | 349 | 132 | 10 | int:MAGEB2 | |
| Interaction | PARP1 interactions | NEPRO CENPC MAPT ATAD5 RFC1 SRBD1 DDX10 EFTUD2 TAF3 PTPN13 UBP1 CTR9 GNL2 SMARCB1 PINX1 PARN ATM TRMT1L SPRTN SLC27A4 ZNF292 | 1.28e-04 | 1316 | 132 | 21 | int:PARP1 |
| Interaction | AGR2 interactions | FLNA NRAP NRAS ANK3 PCLO ASH1L LARS1 SAXO1 ZZEF1 MYEF2 EFTUD2 TOMM70 ANKRD11 ZNF561 FH HYDIN VAT1 | 1.30e-04 | 934 | 132 | 17 | int:AGR2 |
| Cytoband | 11q22-q23 | 1.30e-04 | 6 | 136 | 2 | 11q22-q23 | |
| Cytoband | 3q12.2 | 3.09e-04 | 9 | 136 | 2 | 3q12.2 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 NRAS RFC1 EFTUD2 SLC38A1 TOMM70 NEO1 ERCC6L2 FH CFAP97 ARAP2 | 1.30e-05 | 434 | 132 | 11 | M15150 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 NRAS RFC1 EFTUD2 SLC38A1 TOMM70 NEO1 ERCC6L2 FH CFAP97 ARAP2 | 1.74e-05 | 448 | 132 | 11 | MM1044 |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | CRISPLD2 FLNA MAPT AAMDC PCLO MSH5 ABCB1 NEDD9 FBN1 NRXN1 ALPP | 2.27e-05 | 461 | 132 | 11 | M14127 |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 4.00e-05 | 124 | 132 | 6 | M7876 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ANK3 MAPT RASSF2 AAMDC MKRN1 HECTD4 MSH5 SPECC1 NEO1 PIGT CDH20 TAF9B LRP4 TBC1D23 ZMAT1 PHLDB2 VAT1 | 4.00e-05 | 1102 | 132 | 17 | M2369 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_DN | 4.72e-05 | 78 | 132 | 5 | M9814 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ANK3 MAPT RASSF2 AAMDC MKRN1 HECTD4 MSH5 SPECC1 NEO1 PIGT CDH20 TAF9B LRP4 TBC1D23 ZMAT1 PHLDB2 VAT1 | 5.12e-05 | 1124 | 132 | 17 | MM1070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | CFAP47 SLC16A9 RASSF2 SPECC1 FAT2 CFAP126 NRXN1 ZMAT1 PALLD HYDIN NEK11 ARAP2 | 5.34e-05 | 600 | 132 | 12 | M39055 |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 5.67e-05 | 132 | 132 | 6 | MM470 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 7.15e-05 | 200 | 132 | 7 | M9889 | |
| Coexpression | GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN | 7.15e-05 | 200 | 132 | 7 | M7177 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CASP8AP2 NEPRO NRAS CENPC ATAD5 PCLO CEP290 ZDBF2 ZBED4 ANKRD11 LRP4 PINX1 ATM TRMT1L | 5.42e-06 | 532 | 131 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 1.55e-05 | 129 | 131 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CASP8AP2 TICRR TRAF1 CENPC ATAD5 CEP290 ZMYM2 RFC1 TAF3 RESF1 ZBED4 GVINP1 PTPRR CTR9 PLCL2 GNL2 BOD1L1 ATM CMAHP CFAP97 ZNF292 | 2.66e-05 | 1252 | 131 | 21 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CASP8AP2 TICRR CENPC ATAD5 ZGRF1 CEP290 ZMYM2 ZDBF2 RFC1 DDX10 ZBED4 GNL2 PINX1 BOD1L1 ATM DMD FH CMAHP CFAP97 SLC27A4 ZNF292 | 2.82e-05 | 1257 | 131 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | DOCK3 CASP8AP2 TICRR CENPC RASSF2 ATAD5 MKRN1 BIVM CEP290 ZMYM2 ZDBF2 RFC1 MYEF2 SLC38A1 TAF9B ZBED4 NRXN1 PTPRR BOD1L1 ATM WDFY3 DMD | 3.24e-05 | 1370 | 131 | 22 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CASP8AP2 ATAD5 AAMDC PCLO CEP290 HECTD4 ZDBF2 NEB NEDD9 NRXN1 LRP4 DMD CDH8 SLC27A4 | 5.34e-05 | 654 | 131 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | DOCK3 CASP8AP2 TICRR CENPC ATAD5 ZGRF1 CEP290 ZMYM2 ZDBF2 RFC1 DDX10 ZBED4 GNL2 PINX1 BOD1L1 ATM DMD FH CMAHP CFAP97 SLC27A4 ZNF292 | 8.27e-05 | 1459 | 131 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | CEP290 ASH1L SRP72 RFC1 NEB ABCB1 DDX10 RESF1 MAST4 TAF9B ANKRD11 WDFY3 ZMAT1 CFAP97 VAT1 | 9.28e-05 | 778 | 131 | 15 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | CRISPLD2 CASP8AP2 CENPC ATAD5 AAMDC PCLO CEP290 ZDBF2 MYEF2 SLC38A1 PTPN13 TAF9B ATM DMD SPRTN ZMAT1 ZNF292 | 1.21e-04 | 986 | 131 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | 1.41e-04 | 385 | 131 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ATAD5 ZGRF1 CEP290 ZMYM2 BTBD1 AKAP8L TAF3 GNL2 BOD1L1 WDFY3 DMD CDH8 ZNF292 | 1.42e-04 | 629 | 131 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CASP8AP2 ATAD5 PCLO CEP290 ASH1L ZMYM2 GON4L ZDBF2 PIGT ERCC6L2 BOD1L1 DMD CDH8 SLC27A4 ZNF292 | 1.91e-04 | 831 | 131 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | DOCK3 BRIP1 SLC16A9 ATAD5 ACAD9 CEP290 LARS1 ZDBF2 MYEF2 DDX10 SLC38A1 NEDD9 NEO1 PTPN13 CFAP126 CDH20 TAF9B BOD1L1 PALLD EDRF1 CFAP97 | 2.79e-04 | 1479 | 131 | 21 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CASP8AP2 TICRR EPHA6 CENPC RASSF2 ATAD5 CEP290 ZMYM2 ZDBF2 ZBED4 NRXN1 PTPRR BOD1L1 ATM DMD CMAHP ZNF292 | 2.85e-04 | 1060 | 131 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.13e-10 | 189 | 134 | 10 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.13e-10 | 189 | 134 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.54e-09 | 190 | 134 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.50e-09 | 193 | 134 | 9 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 9.79e-09 | 199 | 134 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 187 | 134 | 8 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 187 | 134 | 8 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.06e-07 | 188 | 134 | 8 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.25e-07 | 192 | 134 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.41e-07 | 195 | 134 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.65e-07 | 199 | 134 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.71e-07 | 200 | 134 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 200 | 134 | 8 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.19e-07 | 169 | 134 | 7 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-06 | 182 | 134 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 134 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 134 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 134 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.45e-06 | 184 | 134 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-06 | 185 | 134 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 185 | 134 | 7 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.50e-06 | 185 | 134 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 187 | 134 | 7 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-06 | 189 | 134 | 7 | f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-06 | 189 | 134 | 7 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 190 | 134 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 190 | 134 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.92e-06 | 192 | 134 | 7 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.06e-06 | 194 | 134 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.13e-06 | 195 | 134 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-06 | 195 | 134 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-06 | 195 | 134 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-06 | 196 | 134 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-06 | 196 | 134 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-06 | 197 | 134 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-06 | 197 | 134 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 198 | 134 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.35e-06 | 198 | 134 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.43e-06 | 199 | 134 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.43e-06 | 199 | 134 | 7 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.03e-06 | 153 | 134 | 6 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-06 | 156 | 134 | 6 | d72c2f5f72d269e29033f8728d924e0d4c8772c7 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 158 | 134 | 6 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-06 | 158 | 134 | 6 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.76e-06 | 159 | 134 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 9.75e-06 | 162 | 134 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 98 | 134 | 5 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 1.20e-05 | 168 | 134 | 6 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 170 | 134 | 6 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 171 | 134 | 6 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.33e-05 | 171 | 134 | 6 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 171 | 134 | 6 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-05 | 172 | 134 | 6 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.42e-05 | 173 | 134 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 1.51e-05 | 175 | 134 | 6 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-05 | 177 | 134 | 6 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-05 | 178 | 134 | 6 | b863fc85d2449f25e6cea289459a7bb1f89583fd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-05 | 179 | 134 | 6 | c815eb9f760fe4ca7a5e49beb224659f0b864f22 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 179 | 134 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.77e-05 | 180 | 134 | 6 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 180 | 134 | 6 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 180 | 134 | 6 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 180 | 134 | 6 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 180 | 134 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 180 | 134 | 6 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 1.77e-05 | 180 | 134 | 6 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 1.83e-05 | 181 | 134 | 6 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 181 | 134 | 6 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.83e-05 | 181 | 134 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 181 | 134 | 6 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.95e-05 | 183 | 134 | 6 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 183 | 134 | 6 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 183 | 134 | 6 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.01e-05 | 184 | 134 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 185 | 134 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 2.07e-05 | 185 | 134 | 6 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 186 | 134 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.13e-05 | 186 | 134 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.13e-05 | 186 | 134 | 6 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.13e-05 | 186 | 134 | 6 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-05 | 186 | 134 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 2.20e-05 | 187 | 134 | 6 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 134 | 6 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 2.20e-05 | 187 | 134 | 6 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-05 | 188 | 134 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-05 | 188 | 134 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-05 | 188 | 134 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.26e-05 | 188 | 134 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.26e-05 | 188 | 134 | 6 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 189 | 134 | 6 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.33e-05 | 189 | 134 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 189 | 134 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 189 | 134 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| Disease | CREST syndrome (is_implicated_in) | 1.90e-05 | 2 | 129 | 2 | DOID:0060218 (is_implicated_in) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 2.55e-05 | 39 | 129 | 4 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | carotid artery intima media thickness | 3.01e-05 | 450 | 129 | 10 | EFO_0007117 | |
| Disease | influenza A (H1N1) | 4.10e-05 | 87 | 129 | 5 | EFO_1001488 | |
| Disease | leukemia (implicated_via_orthology) | 7.52e-05 | 19 | 129 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | Bone Marrow failure syndromes | 1.13e-04 | 4 | 129 | 2 | C2931245 | |
| Disease | Bone marrow failure syndrome 2 | 1.13e-04 | 4 | 129 | 2 | C3810350 | |
| Disease | Bone marrow failure syndrome 1 | 1.13e-04 | 4 | 129 | 2 | C3808553 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.49e-04 | 181 | 129 | 6 | DOID:684 (is_implicated_in) | |
| Disease | Duchenne and Becker Muscular Dystrophy | 1.88e-04 | 5 | 129 | 2 | C3542021 | |
| Disease | Becker Muscular Dystrophy | 1.88e-04 | 5 | 129 | 2 | C0917713 | |
| Disease | Progeria | 1.88e-04 | 5 | 129 | 2 | C0033300 | |
| Disease | Muscular Dystrophy, Duchenne | 2.81e-04 | 6 | 129 | 2 | C0013264 | |
| Disease | skin pigmentation measurement | 3.48e-04 | 137 | 129 | 5 | EFO_0007009 | |
| Disease | peripheral neuropathy | 3.93e-04 | 7 | 129 | 2 | EFO_0003100 | |
| Disease | refractive error | 5.96e-04 | 326 | 129 | 7 | MONDO_0004892 | |
| Disease | mitral valve prolapse (is_implicated_in) | 6.69e-04 | 9 | 129 | 2 | DOID:988 (is_implicated_in) | |
| Disease | plasma renin activity measurement | 6.69e-04 | 9 | 129 | 2 | EFO_0006828 | |
| Disease | Neurodevelopmental Disorders | 7.54e-04 | 93 | 129 | 4 | C1535926 | |
| Disease | Abnormality of refraction | 7.70e-04 | 673 | 129 | 10 | HP_0000539 | |
| Disease | mean fractional anisotropy measurement | 8.16e-04 | 95 | 129 | 4 | EFO_0008399 | |
| Disease | status epilepticus (biomarker_via_orthology) | 9.89e-04 | 100 | 129 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | neurotic disorder | 1.03e-03 | 101 | 129 | 4 | EFO_0004257 | |
| Disease | mean corpuscular hemoglobin concentration | TICRR BRIP1 HECTD4 GON4L RFC1 NEB SPECC1 SLC38A1 NEO1 PLCL2 PINX1 HFM1 CMAHP | 1.13e-03 | 1105 | 129 | 13 | EFO_0004528 |
| Disease | body weight | GALNTL6 ARSJ EPHA6 ATAD5 HECTD4 GON4L LINGO2 ZZEF1 SLC38A1 MAST4 NRXN1 PTPRR DMD NEK11 | 1.27e-03 | 1261 | 129 | 14 | EFO_0004338 |
| Disease | IGF-1 measurement | 1.41e-03 | 488 | 129 | 8 | EFO_0004627 | |
| Disease | serum alanine aminotransferase measurement | BRIP1 NRAS RASA3 PCLO HECTD4 LINGO2 ABCB1 FBN1 CDH20 RESF1 PINX1 | 1.54e-03 | 869 | 129 | 11 | EFO_0004735 |
| Disease | pulse pressure measurement, social deprivation | 1.67e-03 | 14 | 129 | 2 | EFO_0005763, EFO_0009696 | |
| Disease | leukemia | 1.81e-03 | 55 | 129 | 3 | C0023418 | |
| Disease | hepcidin:ferritin ratio | 1.81e-03 | 55 | 129 | 3 | EFO_0007901 | |
| Disease | Anilide use measurement | 1.92e-03 | 15 | 129 | 2 | EFO_0009938 | |
| Disease | urate measurement | DOCK3 SHLD2 SLC16A9 ASH1L HECTD4 GON4L NEO1 NRXN1 LRP4 HFM1 CMAHP | 1.95e-03 | 895 | 129 | 11 | EFO_0004531 |
| Disease | colorectal cancer (is_implicated_in) | 2.00e-03 | 121 | 129 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Pontoneocerebellar hypoplasia | 2.19e-03 | 16 | 129 | 2 | cv:C1261175 | |
| Disease | systolic blood pressure, alcohol drinking | 2.45e-03 | 128 | 129 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | cyclic adenosine monophosphate measurement | 2.47e-03 | 17 | 129 | 2 | EFO_0010473 | |
| Disease | bacteriemia | 2.47e-03 | 17 | 129 | 2 | EFO_0003033 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 3.09e-03 | 19 | 129 | 2 | OBA_2045199 | |
| Disease | common carotid intimal medial thickness | 3.19e-03 | 67 | 129 | 3 | EFO_0004860 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.29e-03 | 139 | 129 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | ascending aortic diameter | 3.38e-03 | 140 | 129 | 4 | EFO_0021787 | |
| Disease | wellbeing measurement | 3.45e-03 | 692 | 129 | 9 | EFO_0007869 | |
| Disease | BREAST CANCER | 3.77e-03 | 21 | 129 | 2 | 114480 | |
| Disease | Splenomegaly | 4.14e-03 | 22 | 129 | 2 | C0038002 | |
| Disease | breast cancer, COVID-19 | 4.14e-03 | 22 | 129 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 4.14e-03 | 22 | 129 | 2 | EFO_0009312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVPSSTVEYLKKHGI | 76 | Q9H7C9 | |
| SEHGLDNKIYPKNTK | 1431 | Q96QE3 | |
| KGSYETSKHEKQPPV | 511 | Q9NR48 | |
| HKYKSGIKSTETQPS | 221 | Q9P2B7 | |
| KEQTEKHKSVPGYLS | 921 | Q6UB99 | |
| TCTKPAGKDLHVKYN | 266 | Q14511 | |
| KSYPETVLKHLKGVN | 1086 | Q96M83 | |
| EVSKQSLFYGKKQPH | 826 | Q7Z2Y8 | |
| QKAKYLPKLASGEHI | 161 | Q9H845 | |
| KEKLIYLEHSPNSEG | 251 | Q5M775 | |
| VLYKPHGKNKTAGET | 286 | Q86UB2 | |
| IYANVHKTKKNDDPS | 76 | Q8WZ64 | |
| YESTRKENLPISGHK | 86 | P20930 | |
| EILSKGQHLYKEKPA | 2381 | P11532 | |
| LSKSEDPVHYKSLVG | 1196 | Q9UKL3 | |
| YEGLEKPESKTSIHN | 1126 | Q16720 | |
| HFKYVGTKLPKQTAD | 416 | Q9ULX6 | |
| DTKQAHELAKSYGIP | 126 | P01111 | |
| KFKKTKYGSQEHPIG | 801 | Q14644 | |
| VHTSGEKQKLKATDY | 226 | P50749 | |
| YPKGIHVETLETEKK | 221 | O95453 | |
| DSYSKSGHKPDNIKG | 376 | P08183 | |
| EILAKTPYGHEKKNL | 261 | Q6IWH7 | |
| NPTVTHTKEPETYKK | 256 | Q7RTY1 | |
| GTRSPHIETYLKKEK | 231 | Q13823 | |
| KEDNPSGHTYTLVSK | 166 | P43366 | |
| KAGELISEKKYRQHP | 951 | Q86VF7 | |
| GELSVPEKYKSIHQI | 571 | Q3B7T1 | |
| VGYHGSEIKTPTLDK | 91 | Q5FYB0 | |
| KHISAPEKTYKGGSL | 3551 | Q9Y6V0 | |
| KEKGPQNATDSYVHK | 66 | O43660 | |
| TVTGPLDYESKTKHV | 2226 | Q9NYQ8 | |
| GKGKSESELPHKLYV | 306 | Q96R28 | |
| GKDVESYLQPKAKRH | 221 | Q96BK5 | |
| KSERHGVQSLSKYKP | 361 | Q9H0B8 | |
| KNIKLYPGTGSKSDH | 296 | Q32MH5 | |
| HPKVYINLDKETKTG | 96 | O75380 | |
| PEALKHQGYDTKSDI | 201 | Q8NG66 | |
| VSYKISREHKGDTNP | 916 | P63132 | |
| HKRASEKYKDNPSIS | 931 | Q96QE4 | |
| GKHKNSIDLEYVPRK | 571 | Q7L985 | |
| YKSLPKLVHAKEGFQ | 1036 | Q9ULB1 | |
| PLYKLQKTECGSHTK | 196 | Q6PEW0 | |
| KYSKAGKEQHPVKVV | 3331 | Q9Y4D8 | |
| VSYKISREHKGDTNP | 916 | Q9BXR3 | |
| KSGKPVFIYKHSQDI | 36 | Q15256 | |
| DHTGKSKIPKIYFGT | 236 | Q9BX63 | |
| QKYKNHIGTEIAPEK | 126 | A2PYH4 | |
| KDGKQISPKSDHYTI | 1036 | Q8WX93 | |
| LSKTYNVDKHVPDSG | 101 | P05187 | |
| KKEKGPTLLYEHPET | 96 | Q4G163 | |
| EKTPSEDKLSVKHKY | 731 | Q8NFC6 | |
| HPKGAKTQEKGAYES | 291 | Q13315 | |
| EKHDPLKNTQAKYGS | 41 | Q05DH4 | |
| YKLTGESPIHQKKAA | 3206 | Q4G0P3 | |
| KDYINKHPGDAEKIT | 1566 | Q8IZD9 | |
| QNKSKKGIFPETYIH | 51 | Q9H7D0 | |
| VKHGELKVYKTLDTP | 851 | Q03188 | |
| HYESKTKGTEKIIAE | 2191 | O15078 | |
| KTGLKAHEPTYFTVD | 781 | P21333 | |
| HFTKKKPVAGTYSLQ | 2816 | P35555 | |
| KKSYTLKVEGANPHL | 346 | Q9HBT6 | |
| PHIGYDKAAKIAKTA | 461 | P07954 | |
| YGTKGLKKVVHETPA | 436 | Q9H0C5 | |
| SKSYKSKEPHELVGS | 1881 | Q3T8J9 | |
| IAKGHLKKVTEQYPD | 396 | Q6PD62 | |
| TTKKGFTPLHVAAKY | 561 | Q12955 | |
| KPTKESISSHEGYTQ | 26 | Q5VTH2 | |
| HINKTTDLKTDYFKP | 491 | Q8IY82 | |
| SEEKLSPSYGSDKKH | 1446 | O15021 | |
| HKTSTGAPAAIKKLY | 126 | P40121 | |
| VHEKAKYSTPATLEQ | 276 | Q13206 | |
| HTDLDPGSKKIKYIL | 86 | P55286 | |
| TYKEKVDADTLPHTK | 1176 | Q5T890 | |
| SKVYSKEITITNHGK | 156 | Q6ZTR5 | |
| ELPKLHNTYVGASEK | 746 | Q12923 | |
| HGIKFKPNQYTKIDT | 136 | Q9UF33 | |
| YEHSKPLKQEEATAT | 106 | Q9UHC7 | |
| ESHPSVYKVASGLKE | 236 | O43196 | |
| YKDKHLVKSAEPGEQ | 31 | Q49A17 | |
| HKVYEEKTKLPSSVE | 506 | Q5VWG9 | |
| LDDAKIYSSHAKKPN | 51 | Q9HBM6 | |
| KKQKTDVSTEHPPFY | 621 | Q7Z2T5 | |
| TTHQDDYPIKGLVKT | 171 | Q8IYX7 | |
| EGPKSKKYHSNNLVE | 701 | B5MCY1 | |
| HPYSKDKNSGAGEKK | 81 | Q9P2K5 | |
| YPHKVKTAQVSDERK | 266 | P35251 | |
| LPNKDVYKKHSSLGQ | 1341 | Q9HCM1 | |
| LGKEYTEKTPISEHA | 1131 | Q9P2J5 | |
| KNTEKEPYSNHVFKV | 396 | Q5VWT5 | |
| TKYSSQKVIGTPHAK | 341 | Q6NW34 | |
| SLEIIHKYEPSKEGQ | 381 | Q9UPR0 | |
| NGSHKYKGNSKDVKP | 1146 | Q92859 | |
| KSTVPHFTEEEKYQK | 126 | Q86V20 | |
| KTKPNTKDHGYTTLA | 71 | Q12824 | |
| YHQSKGDPTAKKGTS | 1341 | Q8N3P4 | |
| YSLVDPEKAKALSKH | 491 | O76094 | |
| QHAISTEKIKAKYPD | 101 | Q9NRX4 | |
| KKQHKEGLYLSDTLP | 886 | Q86SQ0 | |
| EELEHVSAPYKTGSK | 306 | Q8N5C6 | |
| EKVPSYPKSTDHLEK | 196 | Q8NEL0 | |
| SHPSDKYIKETNTKN | 261 | Q9Y471 | |
| IGSQKPYRSEEKIKH | 316 | Q8IXR9 | |
| TAESKAEHKKLPQPY | 2701 | A4UGR9 | |
| SQLYAPVKTHKGEKS | 266 | Q8N587 | |
| KGYHKLLTKSVAETP | 956 | Q7Z2Z1 | |
| NVGTKTYLTNHPAKK | 1946 | Q8IZQ1 | |
| YVHTLTITSKGKENK | 396 | Q969N2 | |
| TITSKGKENKPSYIH | 401 | Q969N2 | |
| PELHKTGTYKFQKTE | 586 | Q6P1M0 | |
| SKKKHPELITFKYGN | 646 | Q9NUY8 | |
| VSYKISREHKGDTNP | 916 | P63133 | |
| IEENKPYSLKRGKHV | 2351 | O60281 | |
| KKTDESYHGRQKGPS | 2306 | Q9HCK1 | |
| SKLQSPKHAYVKDDT | 391 | Q13077 | |
| AKTDHGAEIVYKSPV | 701 | P10636 | |
| IEGKDTHYFIKTTTP | 2541 | Q9P273 | |
| AHAQTEVAKKYGLKP | 591 | O94826 | |
| HQKTCGGTYIKIKEP | 201 | Q9H040 | |
| LENHPSVLKYEKIKG | 1091 | Q9P2E3 | |
| SYKSPLIGHQKTDAE | 476 | Q5TYW1 | |
| EYKQVGSHPSFLKEV | 501 | Q9UBW7 | |
| HEQKKSSKRTLPADY | 286 | Q9NZI7 | |
| HTTDYVDEIKKISPK | 241 | Q99536 | |
| YPLGKKHLISKDTEA | 766 | Q86YA3 | |
| TLTQDKKIHTGEKPY | 411 | Q86V71 | |
| SPKGVEAAKELYTHL | 821 | O43149 | |
| DLTLHKKVSAGEKPY | 126 | Q68EA5 | |
| VGHYSITLKPEKCKN | 156 | Q504Y3 | |
| NKYKTIHTGDKTPKC | 546 | B4DXR9 | |
| KPKIEHTYTGGVDSD | 446 | Q15029 | |
| TEVIHGEPIIKKYTK | 721 | Q15063 | |
| LQTHEKTHTGEKPYK | 381 | Q8N7K0 | |
| SHLEKKKCDEYIPGT | 56 | Q9H2H9 | |
| EKQLPHSKKTYDSFQ | 291 | Q5H9K5 | |
| SYKSPLIGHQKTDAE | 236 | Q4V348 | |
| EKFYDSHPVAKKITS | 646 | O75132 | |
| GGPDHNYTKEKIKIV | 1796 | O75096 | |
| KAGEILSEKKYRQHP | 1706 | P20929 |